Birmingham Children's Hospital
8
1
2
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
33%
1 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Calprotectin and Gut Disease Study
Role: collaborator
Next Generation Home Vision Assessment
Role: collaborator
Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia
Role: collaborator
Evaluation of Low Phenylalanine Formulas
Role: collaborator
Acceptability and Tolerance of a Ready-to-use Protein Substitute in Tablet Form for the Dietary Management of Phenylketonuria
Role: collaborator
Clinical Outcomes From Treatment and Evaluation of Obstructive Sleep Apnoea in Children With Down Syndrome
Role: collaborator
Genetic Determinants of Kawasaki Disease
Role: collaborator
Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.
Role: collaborator
All 8 trials loaded